Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 23085928)

1.

Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidney.

Baran TM, Wilson JD, Mitra S, Yao JL, Messing EM, Waldman DL, Foster TH.

J Biomed Opt. 2012 Sep;17(9):98002-1. doi: 10.1117/1.JBO.17.9.098002.

2.
3.

In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland.

Lee LK, Whitehurst C, Pantelides ML, Moore JV.

Photochem Photobiol. 1995 Nov;62(5):882-6.

PMID:
8570727
4.

Feasibility of interstitial diffuse optical tomography using cylindrical diffusing fibers for prostate PDT.

Liang X, Wang KK, Zhu TC.

Phys Med Biol. 2013 May 21;58(10):3461-80. doi: 10.1088/0031-9155/58/10/3461. Epub 2013 Apr 30.

5.

Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.

Lilge L, Molpus K, Hasan T, Wilson BC.

Photochem Photobiol. 1998 Sep;68(3):281-8.

PMID:
9747583
6.

In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.

Zhu TC, Hahn SM, Kapatkin AS, Dimofte A, Rodriguez CE, Vulcan TG, Glatstein E, Hsi RA.

Photochem Photobiol. 2003 Jan;77(1):81-8.

PMID:
12856887
7.

Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.

Zhu TC, Dimofte A, Finlay JC, Stripp D, Busch T, Miles J, Whittington R, Malkowicz SB, Tochner Z, Glatstein E, Hahn SM.

Photochem Photobiol. 2005 Jan-Feb;81(1):96-105.

8.

Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX.

Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W, Baumgartner R.

Lasers Surg Med. 2007 Jun;39(5):386-93.

PMID:
17565715
9.
10.

Optical properties of adenocarcinoma and squamous cell carcinoma of the gastroesophageal junction.

Holmer C, Lehmann KS, Wanken J, Reissfelder C, Roggan A, Mueller G, Buhr HJ, Ritz JP.

J Biomed Opt. 2007 Jan-Feb;12(1):014025.

PMID:
17343500
11.

Integrating sphere effect in whole bladder wall photodynamic therapy: I. 532 nm versus 630 nm optical irradiation.

van Staveren HJ, Beek JF, Ramaekers JW, Keijzer M, Star WM.

Phys Med Biol. 1994 Jun;39(6):947-59.

PMID:
15551572
12.
13.

Evaluation of a fiberoptic-based system for measurement of optical properties in highly attenuating turbid media.

Sharma D, Agrawal A, Matchette LS, Pfefer TJ.

Biomed Eng Online. 2006 Aug 23;5:49.

14.
15.

In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates.

Solonenko M, Cheung R, Busch TM, Kachur A, Griffin GM, Vulcan T, Zhu TC, Wang HW, Hahn SM, Yodh AG.

Phys Med Biol. 2002 Mar 21;47(6):857-73.

PMID:
11936174
16.

Minimally invasive photodynamic therapy (PDT) for ablation of experimental rat glioma.

Hirschberg H, Spetalen S, Carper S, Hole P, Tillung T, Madsen S.

Minim Invasive Neurosurg. 2006 Jun;49(3):135-42.

PMID:
16921452
17.

Photodynamic therapy with motexafin lutetium for rectal cancer: a preclinical model in the dog.

Ross HM, Smelstoys JA, Davis GJ, Kapatkin AS, Del Piero F, Reineke E, Wang H, Zhu TC, Busch TM, Yodh AG, Hahn SM.

J Surg Res. 2006 Oct;135(2):323-30. Epub 2006 May 2.

PMID:
16650871
18.

Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumours.

Shackley DC, Whitehurst C, Moore JV, George NJ, Betts CD, Clarke NW.

BJU Int. 2000 Oct;86(6):638-43.

PMID:
11069369
19.

Photodynamic therapy as novel nephron sparing treatment option for small renal masses.

Kroeze SG, Grimbergen MC, Rehmann H, Bosch JL, Jans JJ.

J Urol. 2012 Jan;187(1):289-95. doi: 10.1016/j.juro.2011.09.006. Epub 2011 Nov 17.

PMID:
22099991
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk